407 related articles for article (PubMed ID: 19350585)
1. The hope but challenge for developing a vaccine that might control malaria.
Good MF
Eur J Immunol; 2009 Apr; 39(4):939-43. PubMed ID: 19350585
[TBL] [Abstract][Full Text] [Related]
2. Overview: immunology of malaria and progress in malaria vaccine development.
Tharavanij S
Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
[No Abstract] [Full Text] [Related]
3. The immunological challenge to developing a vaccine to the blood stages of malaria parasites.
Good MF; Stanisic D; Xu H; Elliott S; Wykes M
Immunol Rev; 2004 Oct; 201():254-67. PubMed ID: 15361246
[TBL] [Abstract][Full Text] [Related]
4. [The immunological aspects of tropical malaria related to the development of an antimalarial vaccine].
Chirkov VP; Popov AF
Med Parazitol (Mosk); 2000; (2):56-8. PubMed ID: 10900926
[No Abstract] [Full Text] [Related]
5. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.
Cowman AF; Baldi DL; Duraisingh M; Healer J; Mills KE; O'Donnell RA; Thompson J; Triglia T; Wickham ME; Crabb BS
Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):25-33. PubMed ID: 11839179
[TBL] [Abstract][Full Text] [Related]
6. Parasitology. Malaria--from infants to genomics to vaccines.
Long CA; Hoffman SL
Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768
[No Abstract] [Full Text] [Related]
7. Vaccinating with the genome: a Sisyphean task?
Coppel RL
Trends Parasitol; 2009 May; 25(5):205-12. PubMed ID: 19359219
[TBL] [Abstract][Full Text] [Related]
8. Malaria vaccine development: lessons from the field.
Todryk S; Bejon P
Eur J Immunol; 2009 Aug; 39(8):2007-10. PubMed ID: 19672893
[TBL] [Abstract][Full Text] [Related]
9. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
Patarroyo ME; Patarroyo MA
Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
[TBL] [Abstract][Full Text] [Related]
10. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
Ballou WR; Kester KE; Heppner DG
Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
[No Abstract] [Full Text] [Related]
11. The case for a subunit vaccine against malaria.
Anders RF
Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861
[TBL] [Abstract][Full Text] [Related]
12. Malaria vaccines: the stage we are at.
Todryk SM; Hill AV
Nat Rev Microbiol; 2007 Jul; 5(7):487-9. PubMed ID: 17571459
[No Abstract] [Full Text] [Related]
13. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
Bermúdez A; Reyes C; Guzmán F; Vanegas M; Rosas J; Amador R; Rodríguez R; Patarroyo MA; Patarroyo ME
Vaccine; 2007 May; 25(22):4487-501. PubMed ID: 17403557
[TBL] [Abstract][Full Text] [Related]
14. Plasmodium falciparum serine repeat antigen 5 (SE36) as a malaria vaccine candidate.
Palacpac NM; Arisue N; Tougan T; Ishii KJ; Horii T
Vaccine; 2011 Aug; 29(35):5837-45. PubMed ID: 21718740
[TBL] [Abstract][Full Text] [Related]
15. The dog that did not bark: malaria vaccines without antibodies.
Heppner DG; Schwenk RJ; Arnot D; Sauerwein RW; Luty AJ
Trends Parasitol; 2007 Jul; 23(7):293-6. PubMed ID: 17512252
[TBL] [Abstract][Full Text] [Related]
16. A review of human vaccine research and development: malaria.
Girard MP; Reed ZH; Friede M; Kieny MP
Vaccine; 2007 Feb; 25(9):1567-80. PubMed ID: 17045367
[TBL] [Abstract][Full Text] [Related]
17. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS
Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269
[TBL] [Abstract][Full Text] [Related]
18. [Soluble antigens of intra-erythrocyte stages of Plasmodium falciparum: diagnostic and vaccinal value].
Cruz Cubas AB; Gentilini M; Danis M; Monjour L
Pathol Biol (Paris); 1993 May; 41(5):495-9. PubMed ID: 8414684
[TBL] [Abstract][Full Text] [Related]
19. The Plasmodium sporozoite survives RTS,S vaccination.
Snounou G; Grüner AC; Müller-Graf CD; Mazier D; Rénia L
Trends Parasitol; 2005 Oct; 21(10):456-61. PubMed ID: 16109504
[TBL] [Abstract][Full Text] [Related]
20. Protection against Plasmodium falciparum challenge induced in Aotus monkeys by liver-stage antigen-3-derived long synthetic peptides.
Perlaza BL; Valencia AZ; Zapata C; Castellanos A; Sauzet JP; Blanc C; Cohen J; Arévalo-Herrera M; Corradin G; Herrera S; Druilhe P
Eur J Immunol; 2008 Sep; 38(9):2610-5. PubMed ID: 18792413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
